699 related articles for article (PubMed ID: 16076368)
1. Therapeutic strategy and the role of apheresis therapy for ABO incompatible living donor liver transplantation.
Kozaki K; Egawa H; Kasahara M; Oike F; Yoshizawa A; Fukatsu A; Tanaka K
Ther Apher Dial; 2005 Aug; 9(4):285-91. PubMed ID: 16076368
[TBL] [Abstract][Full Text] [Related]
2. The role of apheresis therapy for ABO incompatible living donor liver transplantation: the Kyoto University experience.
Kozaki K; Egawa H; Ueda M; Oike F; Yoshizawa A; Fukatsu A; Takada Y
Ther Apher Dial; 2006 Oct; 10(5):441-8. PubMed ID: 17096700
[TBL] [Abstract][Full Text] [Related]
3. The role of plasmapheresis therapy for perioperative management in ABO-incompatible adult living donor liver transplantation.
Ashizawa T; Matsuno N; Yokoyama T; Kihara Y; Kuzuoka K; Taira S; Konno O; Jyojima Y; Akashi I; Nakamura Y; Hama K; Iwamoto H; Iwahori T; Nagao T; Kasahara M; Tanaka K
Transplant Proc; 2006 Dec; 38(10):3629-32. PubMed ID: 17175351
[TBL] [Abstract][Full Text] [Related]
4. Experiences and problems pre-operative anti-CD20 monoclonal antibody infusion therapy with splenectomy and plasma exchange for ABO-incompatible living-donor liver transplantation.
Usui M; Isaji S; Mizuno S; Sakurai H; Uemoto S
Clin Transplant; 2007; 21(1):24-31. PubMed ID: 17302588
[TBL] [Abstract][Full Text] [Related]
5. The role of apheresis therapy in living donor liver transplantation.
Kozaki K; Fukatsu A; Kasahara M; Ogura Y; Egawa H; Tanaka K
Ther Apher Dial; 2004 Jun; 8(3):174-9. PubMed ID: 15154866
[TBL] [Abstract][Full Text] [Related]
6. New protocol of immunosuppression for liver transplantation across ABO barrier: the use of Rituximab, hepatic arterial infusion, and preservation of spleen.
Yoshizawa A; Sakamoto S; Ogawa K; Kasahara M; Uryuhara K; Oike F; Ueda M; Takada Y; Egawa H; Tanaka K
Transplant Proc; 2005 May; 37(4):1718-9. PubMed ID: 15919443
[TBL] [Abstract][Full Text] [Related]
7. Adult living-donor liver transplantation with ABO-incompatible grafts.
Testa G; Vidanovic V; Chejfec G; Gangemi A; Iqpal R; Porubsky M; Pham T; Benedetti E
Transplantation; 2008 Mar; 85(5):681-6. PubMed ID: 18337660
[TBL] [Abstract][Full Text] [Related]
8. Successful case of adult ABO-incompatible liver transplantation: beneficial effects of intrahepatic artery infusion therapy: a case report.
Nakamura Y; Matsuno N; Iwamoto H; Yokoyama T; Kuzuoka K; Kihara Y; Taira S; Sagara T; Jojima Y; Konno O; Tashiro J; Akashi I; Hama K; Narumi K; Iwahori T; Uchiyama M; Tanaka K; Nagao T
Transplant Proc; 2004 Oct; 36(8):2269-73. PubMed ID: 15561215
[TBL] [Abstract][Full Text] [Related]
9. ABO-incompatible adult living donor liver transplantation for hepatocellular carcinoma.
Matsuno N; Iwamoto H; Nakamura Y; Hama K; Kihara Y; Konno O; Jojima Y; Akashi I; Mijiti A; Ashizawa T; Nagao T
Transplant Proc; 2008 Oct; 40(8):2497-500. PubMed ID: 18929778
[TBL] [Abstract][Full Text] [Related]
10. Effects and problems of adult ABO-incompatible living donor liver transplantation using protocol of plasma exchange, intra-arterial infusion therapy, and anti-CD20 monoclonal antibody without splenectomy: case reports of initial experiences and results in Korea.
Kim BW; Park YK; Kim YB; Wang HJ; Kim MW
Transplant Proc; 2008 Dec; 40(10):3772-7. PubMed ID: 19100487
[TBL] [Abstract][Full Text] [Related]
11. Rituximab, IVIG, and plasma exchange without graft local infusion treatment: a new protocol in ABO incompatible living donor liver transplantation.
Ikegami T; Taketomi A; Soejima Y; Yoshizumi T; Uchiyama H; Harada N; Iguchi T; Hashimoto N; Maehara Y
Transplantation; 2009 Aug; 88(3):303-7. PubMed ID: 19667930
[TBL] [Abstract][Full Text] [Related]
12. B-cell surface marker analysis for improvement of rituximab prophylaxis in ABO-incompatible adult living donor liver transplantation.
Egawa H; Ohmori K; Haga H; Tsuji H; Yurugi K; Miyagawa-Hayashino A; Oike F; Fukuda A; Yoshizawa J; Takada Y; Tanaka K; Maekawa T; Ozawa K; Uemoto S
Liver Transpl; 2007 Apr; 13(4):579-88. PubMed ID: 17394164
[TBL] [Abstract][Full Text] [Related]
13. Adult ABO-incompatible liver transplantation, using A and B donors.
Skogsberg U; Breimer ME; Friman S; Mjörnstedt L; Mölne J; Olausson M; Rydberg L; Svalander CT; Bäckman L
Xenotransplantation; 2006 Mar; 13(2):154-9. PubMed ID: 16623811
[TBL] [Abstract][Full Text] [Related]
14. Dual living donor liver transplantation with ABO-incompatible and ABO-compatible grafts to overcome small-for-size graft and ABO blood group barrier.
Song GW; Lee SG; Hwang S; Kim KH; Ahn CS; Moon DB; Ha TY; Kwon SW; Ko GY; Kim KW
Liver Transpl; 2010 Apr; 16(4):491-8. PubMed ID: 20222051
[TBL] [Abstract][Full Text] [Related]
15. Discrepancy of B cell frequency between periphery and spleen after rituximab treatment in ABO-incompatible liver transplantation.
Iso Y; Sawada T; Kita J; Shiraki T; Sakuraoka Y; Kato M; Shimoda M; Kubota K
Hepatogastroenterology; 2013 Oct; 60(127):1624-6. PubMed ID: 24634932
[TBL] [Abstract][Full Text] [Related]
16. Impact of intraportal donor-specific leukocyte transfusion for adult ABO-incompatible liver transplantation.
Oya H; Sato Y; Yamamoto S; Nakatsuka H; Kobayashi T; Watanabe T; Hara Y; Kokai H; Hatakeyama K
Transplant Proc; 2009; 41(1):222-5. PubMed ID: 19249519
[TBL] [Abstract][Full Text] [Related]
17. Long-term follow-up ABO-incompatible adult living donor liver transplantation in cirrhotic patients.
Matsuno N; Nakamura Y; Mejit A; Hama K; Iwamoto H; Konno O; Jojima Y; Akashi I; Iwahori T; Ashizawa T; Nagao T
Clin Transplant; 2007; 21(5):638-42. PubMed ID: 17845639
[TBL] [Abstract][Full Text] [Related]
18. Management of anti-allogeneic antibody elimination by apheresis in living donor liver transplantation.
Kawagishi N; Takeda I; Miyagi S; Satoh K; Akamatsu Y; Sekiguchi S; Fujimori K; Sato T; Satomi S
Ther Apher Dial; 2007 Oct; 11(5):319-24. PubMed ID: 17845390
[TBL] [Abstract][Full Text] [Related]
19. Splenectomy does not offer immunological benefits in ABO-incompatible liver transplantation with a preoperative rituximab.
Raut V; Mori A; Kaido T; Ogura Y; Taku I; Nagai K; Sasaki N; Endo K; Hata T; Yagi S; Egawa H; Uemoto S
Transplantation; 2012 Jan; 93(1):99-105. PubMed ID: 22094955
[TBL] [Abstract][Full Text] [Related]
20. ABO-incompatible live donor renal transplantation using blood group A/B carbohydrate antigen immunoadsorption and anti-CD20 antibody treatment.
Nordén G; Briggs D; Cockwell P; Lipkin G; Mjörnstedt L; Mölne J; Ready A; Rydberg L; Samuelsson O; Svalander CT; Breimer ME
Xenotransplantation; 2006 Mar; 13(2):148-53. PubMed ID: 16623810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
